The GIMEMA ALL 0183 trial: Analysis of 10-year follow-up

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 665-672

  Mandelli, Franco ^a,c   Annino, Luciana ^a   Rotoli, Bruno ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Haematology   (Italy)

Author keywords

Acute lymphoblastic leukaemia; Chemotherapy; CNS prophylaxis; Post relapse survival; Survival; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0029997676     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00394.x     Document Type: Article

References (34)

1. Arcese, W., Amadori, S., Meloni, G., Giona, F., Vegna, M.L., Testi, A.M., Annino, L., Carotenuto, M., Resegotti, L., Madon, E., Leoni, P., Zanesco, L. & Mandelli, F., for the AIEOP/GIMEMA Group (1991) Allogeneic or autologous bone marrow transplantation for intensification of salvage therapy in patients with high-risk advanced acute lymphoblastic leukemia. Seminars in Hematology, 28, (Suppl. 4), 116-121.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1981) The morphologic classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. British Journal of Haematology, 47, 553-558.
3. Clarkson, B., Gaynor, J., Little, E., Berman, E., Kemfin, S., Andreeff, M., Gulati, S., Cunningham, I. & Gee, T. (1990) Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Haematology and Blood Transfusion, Vol. 33 (eds Buchner, Schellong, Hiddemann & Ritter), pp. 397-408.
4. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society B, 34, 187-220.
5. Doney, K., Fisher, L.D., Appelbaum, F.D., Buckner, C.D., Storb, R., Singer, J., Fefer, A., Anasetti, C., Beatty, P., Bensinger, W., Clift, R., Hansen, J., Hill, R., Loughran, T.P., Martin, P., Petersen, F.B., Sanders, J., Sullivan, K.M., Stewart, P., Weiden, P., Witherspoon, R. & Thomas, E.D. (1991) Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation: multivariate analysis of factors affecting acute graft versus-host disease, and relapse-free survival. Bone Marrow Transplantation, 7, 453-459.
6. Durrant, I.J. & Richards, S.M. (1993) Results of Medical Research Council Trial UK ALL IX in acute lymphoblastic leukaemia in adults: report from Medical Research Council Working Party on Adult Leukaemia. British Journal of Haematology, 85, 84-92.
7. Ellison, R.R., Mick, R., Cuttner, J., Schiffer, C.A., Silver, R.T., Henderson, E.S., Woliver, T., Royston, I., Davey, F.R., Glicksman, A.S., Bloomfield, C.D. & Holland, J.F. (1991) The effects of post-induction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. Journal of Clinical Oncology, 9, 2002-2015.
8. Evensen, S.A., Brinch, L., Tjonnfjord, G., Stavem, P. & Wisloff, F. (1994) Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia. British Journal of Haematology, 88, 88-93.
9. Fiére, D., Extra, J.M., David, B., Witz, F., Vernant, J.P., Gastant, J.A., Davriac, C., Pris, J. & Marty, M. (1987) Treatment of 218 adult acute lymphoblastic leukemias. Seminars in Oncology, 14, 64-66.
10. Fiére, D., Lepage, E., Sebban, C., Boucheix, C., Gisselbrecht C., Vernant, J.P., Varet, B., Brouste, A., Cahn, J.Y., Rigal-Huguet, F. Witz, F., Michaux, J.L., Michallet, M. & Rieffers, J., for the French Group of Therapy for Adult Acute Lymphoblastic Leukemia (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as post-remission therapy. Journal of Clinical Oncology, 11, 1990-2001.
11. Finnish Leukemia Group (1992) Long-term survival in acute lymphoblastic leukemia in adults. European Journal of Hematology, 48, 75-82.
12. Freund, M., Diedrich, H., Ganser, A., Gramatzki, M., Heil, G., Heyll, A., Henke, M., Hiddemann, W., Haas, R., Kuse, R., Koch, P., Link, H., Maschmeyer, G., Planker, M., Queiber, W., Schadeck-Gressel, C., Schmitz, N., Von Verschuer, U., Wilhelm, S., Thiel, E. & Hoelzer, D. (1992) Treatment of relapsed or refractory adult acute lymphoblastic leukemia. Cancer, 69, 709-716.
13. Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T. & Clarkson, B. (1988) A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital Experience since 1969. Journal of Clinical Oncology, 6, 1014-1030.
14. Giona, F., Testi, A.M., Annino, L., Amadori, S., Arcese, W., Camera, A., Cordero di Montezemolo, L., Ladogana, S., Liso, V., Meloni, G., Moleti, M.L., Rondelli, R., Zanesco, L., Pession, L. & Mandelli, F. (1994) Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/ AIEOP experience. British Journal of Haematology, 86, 55-61.
15. Hiddemann, W., Buchner, T., Heil, G., Schumacher, K., Diedrich, G., Maschmeyer, G., Ho, A.D., Planker, M., Gerith-Stolzenburg, S., Donhuijsenant, R., Lengfelder, E. & Hoelzer, D. (1990) Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). Leukemia, 4, 637-640.
16. Hoelzer, D., Thiel, E., Loffler, H., Buchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Diedrich, H., Ruhl, H., Maschmeyer, G., Lipp, T., Nowrousian, M.R., Burkert, M., Gerecke, D., Pralle, H., Muller, V., Lunscken, C.H., Fulle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Gorg, C.H., Emmerich, B., Braumann, D., Vaupel, H.A., Von Paleske, A., Bartels, H., Neiss, A. & Messerer, D. (1989) Prognostic factors in a multicentric study for treatment of acute lymphoblastic leukemia in adults. Blood, 71, 123-131.
17. Horowitz, M.M., Messerer, D., Hoelzer, D., Gale, R.P., Neiss, A., Atkinson, K., Barret, A.J., Buchner, T., Freund, M., Heil, G., Hiddeman, W., Kolb, A.J., Loeffler, H., Marmont, A.M., Maschmeyer, G., Rimm, A.A., Rozman, C., Sobocinsky, K.A., Speck, B., Thiel, E., Weisdorf, D.J., Zwaan, F.E. & Bortin, M.M. (1991) Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Annals of Internal Medicine, 115, 13-18.
18. Hussein, K., Dahlberg, S., Head, D., Waddell, C., Dalich, L., Wetck, J.K., Morrison, F., Saiki, J.H., Metz, E., Rivkim, S.E., Grever, M.R., Boldt, D., and Southwest Oncology Group (1989) Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation and maintenance chemotherapy. Blood, 73, 57-63.
19. Kantarjian, H.M., Walters, R.I., Keating, M.I., Estey, E.H., O'Brien, S., Schachner, J., McCredie, K.B. & Freireich, E.J. (1990) Mitoxantrone and high dose cytosine arabinoside for the treatment of refractory acute lymphoblastic leukemia. Cancer, 65, 5-8.
20. Kaplan, E.I. & Meyer, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
21. Linker, C.A., Levitt, L.J., O'Dannel, M., Forman, S.J. & Ries, C.A. (1991) Treatment of acute lymphoblastic leukemia with intensive chemotherapy: a follow-up report. Blood, 78, 2814-2822.
22. Lister, T.A., Whitehouse, J.M.A., Beard, M.E.J., Brearly, R.L., Wrigley, P.F.M., Oliver, R.T.D., Freeman, J.E., Woodruff, R.K., Malpas, J.S., Paxton, A.M. & Crowther, D. (1978) Combination chemotherapy for acute lymphoblastic leukaemia in adults. British Medical Journal, i, 199-203.
23. Mandelli, P., Rotoli, B., Aloe Spiriti, M.A., for the GIMEMA Cooperative Group (1989) GIMEMA ALL0183: a multicentric study on adult acute lymphoblastic leukaemia in Italy. British Journal of Haematology, 71, 377-386.
24. Mandelli, F., Annino, L., Giona, F., Vegna, M.L., Bizzi, B., Broccia, G., Fioritoni, G., Liso, V., Martelli, M., Peta, A., Resegotti, L., Rotoli, B., for the GIMEMA Cooperative Group (1990) GIMEMA ALL 0183: a multicentric study on adult acute lymphoblastic leukemia in Italy. Acute Lymphoblastic Leukemia (ed. by R. P. Gale and D. Hoelzer), pp. 205-220. Alan R. Liss, New York.
25. Mandelli, F., Annino, L., Vegna, M.L., Camera, A., Ciolli, S., Deplano, W., Fabbiano, F., Ferrara, F., Ladogana, S., Muti, G., Peta, A., Recchia, A., Sica, S., Stasi, R., Tabilio, A., Visani, G. & Baccarani, M., for the GIMEMA Group (1992) GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia: preliminary results. Leukemia, 6, (Suppl. 2), 182-185.
26. Omura, G.A. & Raney, M. (1985) Long-term survival in adult acute lymphoblastic leukemia: follow-up of Southeastern Cancer Group trial. Journal of Clinical Oncology, 3, 1053-1058.
27. Peto, R., Pike, M.L., Armitage, P. & Breslow, M.E. (1977) Design and analysis of randomized clinical trials requiring prolonged observations of each patient. British Journal of Cancer, 35, 1-39.
28. Preti, A. & Kantarjian, H.M. (1994) Management of adult acute lymphocytic leukemia: present issue and key challenges. Journal of Clinical Oncology, 12, 1312-1322.
29. Proctor, S.J. (1994) Acute lymphoblastic leukaemia in adults: the case for a strategic shift in study approach. British Journal of Haematology, 88, 229-233.
30. Schauer, P., Arlin, Z.A., Miertelsmann, R., Cirrincione, C., Friedman, A., Gee, T.S., Dowling, M., Dufour, P., Little, C. & Dell'Aquila, C. (1983) Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. Journal of Clinical Oncology, 1, 462-470.
31. Sebban, C., Lepage, E., Vernant, J.P., Gluckman, E., Attal, M., Reffeirs, J., Sutton, L., Racadot, E., Michallet, M., Maraninchi, D., Dreyfus, F. & Fière, D., for the French Group of Therapy of Adult Lymphoblastic Leukemia (1994) Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. Journal of Clinical Oncology, 12, 2580-2587.
32. Stryckmans, P., de Witte, T.H., Fillet, G., Marie, J.P., Peetermaans, M., Hayat, M., Labar, B., Jacksic, B., Roozendaal, K., Suciu, S. & Sabin, G., for the EORTC Leukemia Group (1991) Treatment of adult acute lymphoblastic leukemia: ALL2 and ALL3 RORTC studies. Haematologica, 76, (Suppl. 4), 109.
33. Weiss, M., Berman, E., Maslack, P., Bertino, J., Clarkson, B., Nichols, G., Alvarez, A., Gee, T., Scheinberg, D. & Golde, D. (1993) Rapid remission induction therapy in adult lymphoblastic leukemia (ALL) without vincristine or prednisone. ASCO Proceedings, 12, 314 (abstract 1038).
34. Wingard, J.R., Piantadosi, S., Santos, G.W., Saral, R., Wriesendorp, H.M., Yeager, A.M., Burns, W.H., Ambinder, F., Braine, H.G., Elfenbein, G., Jones, R.J., Kaizer, H., May, W.S., Rowley, S.D., Sensenbrenner, L.L., Stuart, R.K., Tutschka, P.J., Voghelsang, G.B., Wagner, J.E., Beschorner, W.E., Brookmeyer, R. & Farmer, E.R. (1990) Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia. Journal of Clinical Oncology, 8, 820-830.